Microba Life Sciences Ltd
ASX:MAP
Microba Life Sciences Ltd
Stock-Based Compensation
Microba Life Sciences Ltd
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Microba Life Sciences Ltd
ASX:MAP
|
Stock-Based Compensation
AU$814.3k
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Stock-Based Compensation
AU$1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Stock-Based Compensation
AU$3.4m
|
CAGR 3-Years
33%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
|
Apiam Animal Health Ltd
ASX:AHX
|
Stock-Based Compensation
AU$778k
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Microba Life Sciences Ltd
Glance View
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm specializes in the analysis of gut microbiome and promotes development in pathology services, therapeutics and diagnostics based on the microbiome. The firm's flagship product is the Microba Insight, a sampling kit that allows the public to analyze personal gut microbiome. Its discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The company also offers support solutions to researchers.
See Also
What is Microba Life Sciences Ltd's Stock-Based Compensation?
Stock-Based Compensation
814.3k
AUD
Based on the financial report for Jun 30, 2025, Microba Life Sciences Ltd's Stock-Based Compensation amounts to 814.3k AUD.
What is Microba Life Sciences Ltd's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
13%
Over the last year, the Stock-Based Compensation growth was 18%. The average annual Stock-Based Compensation growth rates for Microba Life Sciences Ltd have been 12% over the past three years , 13% over the past five years .
